EMCDDA Home
  • EN

Table INF-106. Notified cases of hepatitis B infection among injecting drug users in the EU: a) Total number of cases where transmission route known, b) number of IDU cases, and c) percentage of IDUs amongst all cases with known risk factor

 

(see the help page for information about formats etc.)

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Wednesday, 23 June 2010